| 1034616-18-6 Basic information More.. |
Product Name: | NMS-P937 (NMS1286937) | Synonyms: | NMS-1286937;4,5-Dihydro-1-(2-hydroxyethyl)-8-[[5-(4-methyl-1-piperazinyl)-2-(trifluoromethoxy)phenyl]amino]-1H-pyrazolo[4,3-h]quinazoline-3-carboxamide;NMS-P937 (NMS1286937);NMS-P937;NMS-1286937,NMS-P937;1-(2-hydroxyethyl)-8-[5-(4-methylpiperazin-1-yl)-2-(trifluoromethoxy)anilino]-4,5-dihydropyrazolo[4,3-h]quinazoline-3-carboxamide;CS-1243;1H-Pyrazolo[4,3-h]quinazoline-3-carboxamide, 4,5-dihydro-1-(2-hydroxyethyl)-8-[[5-(4-methyl-1-piperazinyl)-2-(trifluoromethoxy)phenyl]amino]- | CAS: | 1034616-18-6 | MF: | C24H27F3N8O3 | MW: | 532.52 | EINECS: | | Mol File: | 1034616-18-6.mol | |
NMS-P937 (NMS1286937) manufacturers
- Onvansertib
-
- US $30.00-89.00 / mg
- 2024-11-19
- CAS:1034616-18-6
- Min. Order:
- Purity: 99.88%
- Supply Ability: 10g
|
1034616-18-6
Recommend Suppliers |
|